Together with reduced CSF levels or brain expression of the VGF, Scg2, CgB, and CgA proteins in patients with AD [19, 20], these findings suggest a critical role for VGF in maintaining neuronal activity-modulated synaptic plasticity and cognitive function. Here, SCG2 is linked to Alzheimer disease.